Takeda Pharmaceutical Company Limited (BVMF:TAKP34)

BVMF:TAKP34 Statistics

Total Valuation

BVMF:TAKP34 has a market cap or net worth of BRL 289.72 billion. The enterprise value is 448.23 billion.

Market Cap	289.72B
Enterprise Value	448.23B

Important Dates

The last earnings date was Thursday, January 29, 2026.

Earnings Date	Jan 29, 2026
Ex-Dividend Date	Sep 29, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.25%
Shares Change (QoQ)	+1.77%
Owned by Insiders (%)	0.07%
Owned by Institutions (%)	46.48%
Float	1.58B

Valuation Ratios

The trailing PE ratio is 73.03.

PE Ratio	73.03
Forward PE	n/a
PS Ratio	1.85
PB Ratio	1.08
P/TBV Ratio	n/a
P/FCF Ratio	8.16
P/OCF Ratio	6.94
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.20, with an EV/FCF ratio of 12.63.

EV / Earnings	112.99
EV / Sales	3.02
EV / EBITDA	10.20
EV / EBIT	22.45
EV / FCF	12.63

Financial Position

The company has a current ratio of 1.19, with a Debt / Equity ratio of 0.71.

Current Ratio	1.19
Quick Ratio	0.54
Debt / Equity	0.71
Debt / EBITDA	4.09
Debt / FCF	5.36
Interest Coverage	4.62

Financial Efficiency

Return on equity (ROE) is 1.50% and return on invested capital (ROIC) is 2.76%.

Return on Equity (ROE)	1.50%
Return on Assets (ROA)	2.47%
Return on Invested Capital (ROIC)	2.76%
Return on Capital Employed (ROCE)	4.71%
Weighted Average Cost of Capital (WACC)	3.36%
Revenue Per Employee	3.31M
Profits Per Employee	83,597
Employee Count	47,455
Asset Turnover	0.29
Inventory Turnover	1.16

Taxes

In the past 12 months, BVMF:TAKP34 has paid 3.24 billion in taxes.

Income Tax	3.24B
Effective Tax Rate	44.89%

Stock Price Statistics

The stock price has increased by +20.12% in the last 52 weeks. The beta is 0.08, so BVMF:TAKP34's price volatility has been lower than the market average.

Beta (5Y)	0.08
52-Week Price Change	+20.12%
50-Day Moving Average	81.63
200-Day Moving Average	78.29
Relative Strength Index (RSI)	70.68
Average Volume (20 Days)	18

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BVMF:TAKP34 had revenue of BRL 156.84 billion and earned 3.97 billion in profits. Earnings per share was 2.48.

Revenue	156.84B
Gross Profit	102.77B
Operating Income	21.19B
Pretax Income	7.21B
Net Income	3.97B
EBITDA	44.75B
EBIT	21.19B
Earnings Per Share (EPS)	2.48

Balance Sheet

The company has 23.01 billion in cash and 190.47 billion in debt, with a net cash position of -167.47 billion.

Cash & Cash Equivalents	23.01B
Total Debt	190.47B
Net Cash	-167.47B
Net Cash Per Share	n/a
Equity (Book Value)	268.54B
Book Value Per Share	169.98
Working Capital	17.78B

Cash Flow

In the last 12 months, operating cash flow was 41.77 billion and capital expenditures -6.27 billion, giving a free cash flow of 35.50 billion.

Operating Cash Flow	41.77B
Capital Expenditures	-6.27B
Free Cash Flow	35.50B
FCF Per Share	n/a

Margins

Gross margin is 65.52%, with operating and profit margins of 13.51% and 2.53%.

Gross Margin	65.52%
Operating Margin	13.51%
Pretax Margin	4.60%
Profit Margin	2.53%
EBITDA Margin	28.53%
EBIT Margin	13.51%
FCF Margin	22.64%

Dividends & Yields

This stock pays an annual dividend of 2.82, which amounts to a dividend yield of 3.02%.

Dividend Per Share	2.82
Dividend Yield	3.02%
Dividend Growth (YoY)	0.54%
Years of Dividend Growth	4
Payout Ratio	277.04%
Buyback Yield	-0.25%
Shareholder Yield	2.77%
Earnings Yield	1.37%
FCF Yield	12.25%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BVMF:TAKP34 has an Altman Z-Score of 1.08 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.08
Piotroski F-Score	6